Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Over and out…
Not sure when the ‘last day’ here is - seems to limp over into the next day! How did this get dropped to 4p with a £4k buy at the bell I don’t know. Hopefully the tide will turn when away from AIM. Nasdaq can launch a 1000% day trade on speculation alone.
Yeah, $0.05 per ADR! thats 25% at the current level! So much for having an ISA...
Like a crappy rollercoaster that’s only ever gone downhill, now the theme park will only be open in America - who’s staying on in hope the ride improves?!
Biodexa Pharmaceuticals plc formerly known as Midatech Pharma plc has announced its intention to cancel its listing of ordinary shares from trading on AIM. This is expected to become effective on 26th April 2023.
As the company's American Depository Shares (ADSs) will continue to be traded on NASDAQ, if you choose not to sell your ordinary shares by 17th April 2023, we will arrange for them to be converted to ADSs. The company have stated that any such conversion will not be subject to Stamp Duty or SDRT at 1.5%, neither will it be subject to the usual conversion fee of up to USD0.05 per ADS. Each ADS is equivalent to 5 ordinary shares and as such if your holding is not divisible by 5 you may wish to sell any residual stock before 17th April 2023. The process of converting Ordinary shares to ADSs may take a short period of time; you will not be able to sell the ordinary shares or ADSs during this period. Bank of New York currently charge an annual ADS management fee of USD0.05 per ADS. Any fees charged by Bank of New York for holding the ADSs in future will be passed on to you accordingly. Full details on the ADSs can be found on the website at the following link:
What a total disaster
Yet they are still selling the dream on their website and on LinkedIn. Pathetic management
WTF! this is now half a penny equivalent to pre r/s
Volatile
interactive investor have removed MTPH and replaced with BKT14T0 but neither are currently tradeable! My holding at present appears to be completely removed but this will be for the switch over - not sure which platforms are still trading this?
...
Just how low will this go? Being walked down
thanks for posting - I didn't know you couldn't hold in an ISA.
What do you think you will do?
That link has nothing to do with MTPH?
average down or bail out?
markets pricing in this latest option being voted against - that would be turkeys voting for Christmas if it was. The architects of the failure of the bioasis bid will push this through as this is what they want. Watch a big pump in the US after AIM delisting
He had his hands tied - majority shareholders rejected the Bioasis deal which was much much more attractive without the mega dilution - this option was the only option other than insolvency
What a complete and utter joke this company has become. Nothing more than a shell company for others to short or dump losses into. Now the much promised AIM listing has been scuppered. By the time this converts we will be sub 1p
Stamp should hold his head in shame.
Can see this dropping sub 1p intraday before a March / April pump
0.70 on the bid ffs!
This has been massively manipulated by those who organised the no vote on the Bioasis deal - only genuine solid news on their clinical trials would see a rise. Midatech is a shell company for them to offload and short into